cover image - Pharmacology and the Nursing Process - Elsevier eBook on VitalSource, 10th Edition
ISBN: 9780323827997
Copyright: 2023
Publication Date: 03-30-2022
Page Count: 960
Imprint: Mosby
List Price: $106.99

Pharmacology and the Nursing Process - Elsevier eBook on VitalSource, 10th Edition

by Linda Lane Lilley, PhD, RN, Shelly Rainforth Collins, PharmD, BCGP and Julie S. Snyder, MSN, RN, MEDSURG-BC

Elsevier eBook on VitalSource

cover image - Pharmacology and the Nursing Process - Elsevier eBook on VitalSource, 10th Edition
ISBN: 9780323827997
Copyright: 2023
Publication Date: 03-30-2022
Page Count: 960
Imprint: Mosby
List Price: $106.99
Was $106.99

Now $94.15

Or $0.00 with a valid access code

Gain the pharmacology knowledge and skills you need to administer medications safely! Pharmacology and the Nursing Process, 10th Edition provides practical, easy-to-use pharmacology information, emphasizing the application of the nursing process and prioritization throughout the book. Coverage begins with pharmacology basics, then discusses drugs by body systems and drug functions. Hundreds of full-color illustrations show how drugs work in the body and depict key steps in medication administration. Written by pharmacology experts Linda Lane Lilley, Shelly Rainforth Collins, and Julie S. Snyder, this bestselling textbook makes it easy to understand and apply pharmacology concepts and provide safe, quality nursing care.

    • Focus on need-to-know information includes discussions of what nurses may encounter during drug administration in a variety of health care settings, providing accounts of real-life medication errors and tips for avoiding those errors
    • The Nursing Process is applied to each category of drugs, ensuring that you administer medications accurately and safely, and includes the steps of assessment, human need statements, planning, implementation, and evaluation
    • Emphasis on drug classes describes key similarities and differences among the drugs in each class, making it easier to understand how individual drugs work in the body
    • Consistent presentation for each drug group includes the mechanism of action, indications, contraindications, adverse effects, interactions, and dosages, concluding with drug profiles of individual drugs in the class or group
    • High-alert icons identify medications that pose a greater risk to patient safety
    • Focus on prioritization includes prioritized nursing diagnoses along with a corresponding prioritization of goals and outcomes, to help you learn to connect nursing diagnoses with goals and outcomes
    • Ease of readability makes difficult content more understandable
    • Photo atlas features more than 100 drawings and photographs showing drug administration techniques
    • Dosages tables summarize generic and trade names, pharmacologic class, normal dosage ranges, and indications for the drugs
    • Learning features at the beginning of each chapter include objectives and key terms, and at the end of each chapter, key points, critical thinking questions, review questions, and a list of resources available on the Evolve website
    • QSEN coverage includes the use of human need theory with human need statements, case studies featuring collaboration and teamwork content, Preventing Medication Errors boxes, and a discussion of the QSEN initiative as it relates to the safety and quality of patient care
    • NEW! Updated drug content reflects the latest FDA drug approvals, withdrawals, and therapeutic uses, and includes updated nursing content
  • PART 1: PHARMACOLOGY BASICS
    1. The Nursing Process and Drug Therapy
    2. Pharmacologic Principles
    3. Lifespan Considerations
    4. Cultural, Legal, and Ethical Considerations
    5. Medication Errors: Preventing and Responding
    6. Patient Education and Drug Therapy
    7. Over-the-Counter Drugs and Herbal and Dietary Supplements
    8. Gene Therapy and Pharmacogenomics
    9. Photo Atlas of Drug Administration

    PART 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM
    10. Analgesic Drugs
    11. General and Local Anesthetics
    12. Central Nervous System Depressants and Muscle Relaxants
    13. Central Nervous System Stimulants and Related Drugs
    14. Antiepileptic Drugs
    15. Antiparkinson Drugs
    16. Psychotherapeutic Drugs
    17. Substance Use Disorder

    PART 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM
    18. Adrenergic Drugs
    19. Adrenergic-Blocking Drugs
    20. Cholinergic Drugs
    21. Cholinergic-Blocking Drugs

    PART 4: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS
    22. Antihypertensive Drugs
    23. Antianginal Drugs
    24. Heart Failure Drugs
    25. Antidysrhythmic Drugs
    26. Coagulation Modifier Drugs
    27. Antilipemic Drugs
    28. Diuretic Drugs
    29. Fluids and Electrolytes

    PART 5: DRUGS AFFECTING THE ENDOCRINE AND REPRODUCTIVE SYSTEMS
    30. Pituitary Drugs
    31. Thyroid and Antithyroid Drugs
    32. Antidiabetic Drugs
    33. Adrenal Drugs
    34. Women’s Health Drugs
    35. Men’s Health Drugs

    PART 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM
    36. Antihistamines, Decongestants, Antitussives, and Expectorants
    37. Respiratory Drugs

    PART 7: ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS
    38. Antibiotics Part 1
    39. Antibiotics Part 2
    40. Antiviral Drugs
    41. Antitubercular Drugs
    42. Antifungal Drugs
    43. Antimalarial, Antiprotozoal, and Anthelmintic Drugs
    44. Antiinflammatory and Antigout Drugs

    PART 8: CHEMOTHERAPEUTIC DRUGS AND BIOLOGIC AND IMMUNE MODIFIERS
    45. Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs
    46. Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs
    47. Biologic Response–Modifying and Antirheumatic Drugs
    48. Immunosuppressant Drugs
    49. Immunizing Drugs

    PART 9: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION
    50. Acid-Controlling Drugs
    51. Bowel Disorder Drugs
    52. Antiemetic and Antinausea Drugs
    53. Vitamins and Minerals
    54. Anemia Drugs
    55. Nutritional Supplements

    PART 10: DERMATOLOGIC, OPHTHALMIC, AND OTIC DRUGS
    56. Dermatologic Drugs
    57. Ophthalmic Drugs
    58. Otic Drugs
  • Linda Lane Lilley, PhD, RN, Associate Professor Emeritus, School of Nursing, Old Dominion University, Virginia Beach, Virginia, USA, Shelly Rainforth Collins, PharmD, BCGP, President, Drug Information Consultants, Chesapeake, Virginia, USA and Julie S. Snyder, MSN, RN, MEDSURG-BC, Adjunct Faculty, School of Nursing, Old Dominion University, Virginia Beach, Virginia, USA
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • All content can be read as read aloud speech or dynamic braille
      • Has alternative text descriptions for images
    • Conformance
    • Navigation
      • Table of contents to all chapters of the text via links
      • Index with links to referenced entries
      • Elements such as headings, tables, etc. for structured navigation
      • Page list to go to pages from the print source version
    • Rich Content
      • Math formulas in accessible format (MathML)
      • Information-rich images are described by extended descriptions
    • Hazards
      • The publication contains no hazards
    • Product Content
      • Content includes any type of illustrations.
      • The primary content is text.
      • Content includes maps and/or other cartographic content.
      • Content includes a significant number of actionable (clickable) web links to external content, downloadable resources, supplementary material, etc.
      • Content includes a significant number of actionable (clickable) cross-references, hyperlinked notes and annotations, or with other actionable links between largely textual elements (e.g., quiz/test questions, 'choose your own ending', etc.).
      • Content includes photographs, whether in a plate section / insert or not.
      • Content includes figures, diagrams, charts and/or graphs, including other 'mechanical' (i.e. non-photographic) illustrations.
      • Content includes images displayed in a specific order for the purpose of graphic storytelling or giving information (e.g. graphic novels, comics and manga). May include text integrated into the image (as speech and thought bubbles, textual 'sound' effects, captions etc.).
      • Content includes text within images, including text-as-text embedded in diagrams, charts, or within images containing speech balloons, thought bubbles, captions, etc.
      • Content includes visual content that is purely decorative and is not necessary to understanding of the content.
      • Content includes mathematical notations, formulae.
      • At least some text - including text within other images - is 'text as an image' (i.e., a picture of text).
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
      • Ultra-high contrast between text and background
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • Content provides explanations for unusual words, abbreviations, acronyms, idioms, jargon in an accessible form, such as glossaries, scripted pop-ups.
      • Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Was $106.99

Now $94.15

Or $0.00 with a valid access code